Calcaneal Spur, Plantar Fasciitis
Conditions
Keywords
Plantar Fasciitis, Extracorporeal Shock Wave Therapy, ESWT, Whole Body Vibration Therapy, Foot Function Index, Randomized Controlled Trial
Brief summary
Plantar fasciitis is a common cause of heel pain that can lead to functional limitation and decreased quality of life. Various conservative treatment modalities are used in its management. This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients with plantar fasciitis. The study is designed as a randomized, prospective, single-blind clinical trial. Clinical outcomes will be evaluated using pain and functional assessment scales before and after treatment.
Detailed description
This randomized, prospective, single-blind clinical trial was conducted to compare the effects of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients diagnosed with plantar fasciitis. A total of 60 patients aged between 18 and 65 years were included in the final analysis. Participants were randomly assigned into two groups. The first group received extracorporeal shock wave therapy applied once weekly for a total of five sessions. The second group received whole body vibration therapy three times per week for five weeks. Both groups followed the same standardized home exercise program during the treatment period. Clinical evaluations were performed at baseline, at the end of treatment, and at the ninth week. The primary outcome measure was functional status assessed using the Foot Function Index (FFI). Secondary outcome measures included pain intensity assessed by the Visual Analog Scale (VAS), the American Orthopaedic Foot and Ankle Society (AOFAS) score, and the Roles and Maudsley score.The aim of this study is to determine and compare the clinical effectiveness of ESWT and whole body vibration therapy in the management of plantar fasciitis.
Interventions
DEVICEExtracorporeal Shock Wave Therapy
Extracorporeal shock wave therapy was applied once weekly for a total of five sessions to the affected heel.
Whole body vibration therapy was applied three times per week for five weeks using a vibration platform.
Sponsors
Gaziosmanpasa Research and Education Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Outcome assessors were blinded to group allocation.
Intervention model description
Participants were randomly assigned to one of two parallel groups to receive either extracorporeal shock wave therapy or whole body vibration therapy.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Age between 18 and 65 years * Clinically diagnosed plantar fasciitis * Heel pain lasting at least 4 weeks * Ability to understand the study procedures and provide written informed consent
Exclusion criteria
* History of inflammatory rheumatic diseases * Previous foot or ankle surgery * Major trauma to the foot or ankle * Neurological or vascular disorders of the lower extremities * Pregnancy or lactation * Corticosteroid injection to the foot within the last 3 months * Physical therapy, extracorporeal shock wave therapy, or whole body vibration therapy within the last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Foot Function Index (FFI) | Baseline, 5 weeks and 9 weeks | Foot Function Index (FFI), a self-reported questionnaire consisting of 23 items in three subscales (pain, disability, and activity limitation), with scores ranging from 0 to 100. Higher scores indicate worse foot-related disability. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale (VAS) | Baseline, 5 weeks and 9 weeks | Pain severity assessed using the Visual Analog Scale (VAS).Visual Analog Scale (VAS) for pain, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain. |
| American Orthopaedic Foot and Ankle Society Score (AOFAS) | Baseline, 5 weeks and 9 weeks | American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score, ranging from 0 to 100, where higher scores indicate better function. |
| Roles and Maudsley Score | Baseline, 5 weeks and 9 weeks | Clinical outcome assessed using the Roles and Maudsley score.Roles and Maudsley Score (RM score), a 4-point ordinal scale ranging from 1 (excellent) to 4 (poor). Lower scores indicate better clinical outcome. |
Countries
Turkey (Türkiye)
Contacts
PRINCIPAL_INVESTIGATORBerrin Hüner
Gaziosmanpaşa Training and Research Hospital
Outcome results
None listed